Literature DB >> 10638663

Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome.

O Ortolani1, A Conti, A R De Gaudio, M Masoni, G Novelli.   

Abstract

This study investigates the effects of N-acetylcysteine (NAC) and rutin on the lung oxidative burden of patients with early adult respiratory distress syndrome (ARDS). The protection was evaluated by measuring expired ethane and malondialdehyde (MDA), and oxidized (GSSG) and reduced glutathione (GSH) in the epithelial lining fluid of 36 patients who developed ARDS less than 24 hours before enrollment in the study. The patients were randomly assigned to 3 groups, receiving 250 mL 5% dextrose in water (group 1), NAC 50 mg/kg body weight in 5% dextrose (group 2), and NAC 50 mg/kg + rutin 5 mg/kg in 5% dextrose (group 3). Ethane and MDA concentrations were significantly reduced in the treatment groups after day 6. GSH was 30% increased in the treatment groups. No significant variations were observed in the control group until day 9. The trial confirms that NAC and rutin are efficient in protecting the lungs of patients with ARDS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10638663     DOI: 10.1097/00024382-200013010-00003

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  13 in total

Review 1.  The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

Authors:  J Cranshaw; M J D Griffiths; T W Evans
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

2.  Rethinking antioxidants in the intensive care unit.

Authors:  Manu Jain; Navdeep S Chandel
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

3.  The clinical practice guideline for the management of ARDS in Japan.

Authors:  Satoru Hashimoto; Masamitsu Sanui; Moritoki Egi; Shinichiro Ohshimo; Junji Shiotsuka; Ryutaro Seo; Ryoma Tanaka; Yu Tanaka; Yasuhiro Norisue; Yoshiro Hayashi; Eishu Nango
Journal:  J Intensive Care       Date:  2017-07-25

4.  Pharmacological agents for adults with acute respiratory distress syndrome.

Authors:  Sharon R Lewis; Michael W Pritchard; Carmel M Thomas; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-07-23

Review 5.  Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype?

Authors:  Mairead Hayes; Gerard Curley; Bilal Ansari; John G Laffey
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

Review 6.  N-acetylcysteine for sepsis and systemic inflammatory response in adults.

Authors:  Tamas Szakmany; Balázs Hauser; Peter Radermacher
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

7.  The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients.

Authors:  Atabak Najafi; Mojtaba Mojtahedzadeh; Keyvan Haji Ahmadi; Mohammad Abdollahi; Maryam Mousavi; Legese Chelkeba; Farhad Najmeddin; Arezoo Ahmadi
Journal:  Daru       Date:  2014-07-15       Impact factor: 3.117

8.  Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: A meta-analysis.

Authors:  Ying Zhang; Shaoxue Ding; Caifeng Li; Yifeng Wang; Zhe Chen; Zhiqiang Wang
Journal:  Exp Ther Med       Date:  2017-08-07       Impact factor: 2.447

Review 9.  The Pharmacological Potential of Rutin.

Authors:  Aditya Ganeshpurkar; Ajay K Saluja
Journal:  Saudi Pharm J       Date:  2016-04-30       Impact factor: 4.330

10.  A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.

Authors:  Abbas Taher; Marjan Lashgari; Ladan Sedighi; Farshid Rahimi-Bashar; Jalal Poorolajal; Maryam Mehrpooya
Journal:  Pharmacol Rep       Date:  2021-06-10       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.